Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant (AMA-ALLO)

Toulouse University Hospital

Status

Unknown

Conditions

Hematologic Neoplasms

Treatments

Other: Outpatient assistance program for transplant patients (AMA-ALLO) based on a "navigation" nurse

Study type

Interventional

Funder types

Other

Identifiers

NCT04323605

RC31/16/8771

Details and patient eligibility

About

After the initial monitoring period during hospitalization and isolation, patients with recent transplants are regularly monitored in monthly consultations but are still fragile, immunosuppressed and undergoing many treatments. The implementation of an outpatient assistance program for transplant patients should be feasible and allow for the improvement in medical-psycho-social care for the patients during this fragile and risky period, improve the satisfaction and quality of life for these transplant patients and assist in their socio-professional and familial reintegration.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adult patients over 18 years of age
Having received an allogeneic hematopoietic stem-cell transplant
In full remission
Outpatients
Having given their informed consent for the participation in the outpatient assistance program with a navigation nurse (AMA-ALLO) at the first post-transplant consultation (starting on Day 100 +/- 10 days post-transplant i.e., when the patient passes the initial post-transplant monitoring period in hospitalization (conventional or by day) to the monitoring period in monthly medical consultations) and continuing for 12 months
Affiliated with the social security system

Exclusion criteria

Transplant patients not having given their informed consent for inclusion in AMA-ALLO
Hospitalized or non-outpatient transplant patients
Post-transplant patients in cytological relapse
Patients under a legal regime of adult protection (guardianship, curatorship, etc.)